BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20334466)

  • 21. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
    Adetunji B; Basil B; Mathews M; Osinowo T
    Ann Pharmacother; 2007 Feb; 41(2):359. PubMed ID: 17244643
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
    Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mirtazapine associated with recurrent pancreatitis - a case report.
    Hussain A; Burke J
    J Psychopharmacol; 2008 May; 22(3):336-7. PubMed ID: 18208920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depressed in-patients respond differently to imipramine and mirtazapine.
    Bruijn JA; Moleman P; Mulder PG; van den Broek WW
    Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Pisa syndrome after administration of a single dose of mirtazapine.
    Méndez Guerrero A; Llamas S; Murcia FJ; Ruíz J
    Clin Neuropharmacol; 2013; 36(4):133-4. PubMed ID: 23783006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiety and depression after lung transplantation: Mirtazapine as a first-choice agent?
    Fusar-Poli P; Matteo L; Luca de M; Politi P; Cortesi M; Carboni V
    J Psychosom Res; 2007 Jan; 62(1):101. PubMed ID: 17188127
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.
    Jagsch C; Marksteiner J; Seiringer E; Windhager E
    Pharmacopsychiatry; 2007 May; 40(3):129-31. PubMed ID: 17541890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
    Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of trimipramine on dream recall and dream emotions in depressive outpatients.
    Schredl M; Berger M; Riemann D
    Psychiatry Res; 2009 May; 167(3):279-86. PubMed ID: 19403177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients.
    Shen J; Moller HJ; Wang X; Chung SA; Shapiro GK; Li X; Shapiro CM
    J Clin Psychiatry; 2009 Mar; 70(3):370-7. PubMed ID: 19192466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible mirtazapine-induced rhabdomyolysis.
    Khandat AB; Nurnberger JI; Shekhar A
    Ann Pharmacother; 2004; 38(7-8):1321. PubMed ID: 15187213
    [No Abstract]   [Full Text] [Related]  

  • 34. First report of mirtazapine overdose.
    Hoes MJ; Zeijpveld JH
    Int Clin Psychopharmacol; 1996 Jun; 11(2):147. PubMed ID: 8803652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive dream content without daytime aggressiveness in REM sleep behavior disorder.
    Fantini ML; Corona A; Clerici S; Ferini-Strambi L
    Neurology; 2005 Oct; 65(7):1010-5. PubMed ID: 16217051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients.
    Sinforiani E; Terzaghi M; Pasotti C; Zucchella C; Zambrelli E; Manni R
    Neurol Sci; 2007 Apr; 28(2):96-9. PubMed ID: 17464473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The first film presentation of REM sleep behavior disorder precedes its scientific debut by 35 years].
    Janković SM; Sokić DV; Vojvodić NM; Ristić AJ
    Srp Arh Celok Lek; 2006; 134(9-10):466-9. PubMed ID: 17252919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
    Moustgaard G
    J Clin Psychopharmacol; 2000 Apr; 20(2):268. PubMed ID: 10770470
    [No Abstract]   [Full Text] [Related]  

  • 40. Mirtazapine-induced arthralgia.
    Passier A; van Puijenbroek E
    Br J Clin Pharmacol; 2005 Nov; 60(5):570-2. PubMed ID: 16236049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.